-
1461
Continuous detection of Chikungunya Virus in a passive surveillance system in southern Thailand, 2012-2019.
Published 2025-01-01“…Chikungunya virus (CHIKV) infections are distributed across the globe, causing significant and, often, lasting morbidity. CHIKV vaccines are in development, but their evaluation is limited by the unpredictability of CHIKV transmission, which classically manifests as explosive epidemics separated by variable interepidemic periods. …”
Get full text
Article -
1462
Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
Published 2017-01-01“…Specific immunotherapies, including vaccines with autologous tumor cells and tumor antigen-specific monoclonal antibodies, are important treatments for PC patients. …”
Get full text
Article -
1463
MODERN ASPECTS OF LYSSAVIRUS CLASSIFICATION
Published 2018-04-01“…That's why further investigations of recovered rabies isolates and new vaccine development are of great importance.…”
Get full text
Article -
1464
Recurrent Herpetic Stromal Keratitis in Mice: A Model for Studying Human HSK
Published 2012-01-01“…We will document both differences and similarities that derive from this fundamental difference in these models with an eye towards possible vaccines and therapies that demonstrate promise in treating HSK.…”
Get full text
Article -
1465
The power of health economics and outcomes research (HEOR) in making decisions that matter
Published 2021-12-01“… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
Get full text
Article -
1466
Metal Complexes and Their Potential Therapeutic Role Against COVID-19: Recent Developments in Drug Designing
Published 2021-12-01“…Despite the development of various vaccines, there is still an urgent need to design novel treatments backed with safety data for fighting SARS-CoV-2 and its various mutants. …”
Get full text
Article -
1467
Innate Immune Memory: The Latest Frontier of Adjuvanticity
Published 2015-01-01“…This effect has been most extensively investigated for the tuberculosis vaccine strain Bacillus Calmette-Guérin (BCG). Epidemiological studies suggest that this vaccine is associated with a substantial reduction in overall child mortality that cannot be solely explained by prevention of the target disease but that it seems to rely on inducing resistance to other infections. …”
Get full text
Article -
1468
-
1469
Impact of COVID-19 on routine childhood immunisations in low- and middle-income countries: A scoping review.
Published 2023-01-01“…Routine vaccines are critical to child health. The COVID-19 pandemic significantly impacted essential health services, particularly in low-and middle-income countries (LMICs). …”
Get full text
Article -
1470
The Informed Consent in Allergology from a Scientific, Technological and Social Perspective
Published 2015-11-01“…This paper reviews the application of the informed consent within the specialty of allergology in procedures (skin tests), therapeutic interventions (immunotherapy) and research (clinical trials) from a scientific, technological and social perspective, based on the advances achieved in Cuba in recent years to obtain better allergenic extracts for testing, high-quality vaccines and new drugs to benefit the allergic patient. …”
Get full text
Article -
1471
Megapneumonia Coinfection: pneumococcus, Mycoplasma pneumoniae, and Metapneumovirus
Published 2012-01-01“…We report a young girl who died of Streptococcus pneumoniae 19A pneumonia, septic shock, and hemolytic uremic syndrome despite prior pneumococcal vaccination, appropriate antibiotics, and aggressive intensive care support. …”
Get full text
Article -
1472
Design and Performance of Solar PV Integrated Domestic Vapor Absorption Refrigeration System
Published 2021-01-01“…They can also help lifesaving vaccines to reach even the isolated parts of the world. …”
Get full text
Article -
1473
AAV-based vectors for human diseases modeling in laboratory animals
Published 2025-02-01“…The development of therapeutic drugs and vaccines requires the availability of appropriate model animals that replicate the pathogenesis of human diseases. …”
Get full text
Article -
1474
Strategies to Overcome Antileishmanial Drugs Unresponsiveness
Published 2014-01-01“…In the absence of effective vector control measures and vaccines against leishmaniasis, effective chemotherapy remains the mainstay of treatment. …”
Get full text
Article -
1475
Completely conserved VP2 residue K140 of KREMEN1-dependent enteroviruses is critical for virus-receptor interactions and viral infection
Published 2025-02-01“…Licensed inactivated EV-A71 vaccines do not provide cross-protection against other enteroviruses. …”
Get full text
Article -
1476
Algorithms for Processing Coronavirus Genomes for the Goals and Objectives of Modern Immunoinformatics, Vaccinomics, and Virology
Published 2022-06-01“…However, for the complete analysis and implementation of, for example, the epitope vaccines, subsequent validation by the laboratory and in vivo experiments are required.…”
Get full text
Article -
1477
Aging Adults and Seasonal Influenza: Does the Vitamin D Status (H)Arm the Body?
Published 2012-01-01“…Evidence that VitD affects clearance of selected pathogens is supported by epidemiological and clinical data, while its coadministration with influenza vaccine in mice enhanced both mucosal and systemic antibody responses. …”
Get full text
Article -
1478
Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
Published 2012-01-01“…The progress and limitations in developing a safe and efficient mucosal herpes vaccine are discussed.…”
Get full text
Article -
1479
New Immunotherapeutic Approaches for Glioblastoma
Published 2021-01-01“…The immunotherapies for GMB including monoclonal antibodies, checkpoint inhibitors, vaccines, and oncolytic viruses, among others, have shown favorable results alone or as a multimodal treatment. …”
Get full text
Article -
1480
Anti-HSV-1 agents: an update
Published 2025-01-01“…To date, there are no approved commercially available vaccines, and anti-HSV-1 drugs such as specific or non-specific nucleotide (nucleoside) analogs and helicase-primase inhibitors have become the main clinical agents for the treatment of HSV-1 infections despite challenges from resistance. …”
Get full text
Article